Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / September 29, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Aerie Pharmaceuticals, Inc. (NA...
NEW YORK, NY / ACCESSWIRE / September 25, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Aerie Pharmaceuticals, Inc. (NA...
NEW YORK, NY / ACCESSWIRE / September 22, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Aerie Pharmaceuticals, Inc. (NA...
Webinar to be held Friday, September 23, 2022 @ 10 a.m. ET Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), a pharmaceutical company focused on the discovery, development, and commercialization of first-in-class ophthalmic therapies, today announced that it will host a Ke...
NEW YORK, NY / ACCESSWIRE / August 30, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: CyberOptics Corporation (NASDAQ:CY...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Wirestock Creators / Shutterstock.com Ocugen (NASDAQ: OCGN ) stock is gaining on Tuesday after Mizuho Securities analysts initiated coverage of the medical company’s shares. That coverage starts...
Alcon (NYSE: ALC) and Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) has announced entry into a definitive merger agreement where Alcon will acquire Aerie. Alcon will add commercial products Rocklatan and Rhopressa and a pipeline of several clinical and preclinical o...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock.com Aerie Pharmaceuticals (NASDAQ: AERI ) stock is rising higher on Tuesday following news of an acquisition deal with Alcon (NYSE: ALC ). Alcon is agreeing to acquire Aerie Pharma...
After a solid summer rally, the stock market gave back some ground on Monday. However, the mood on Wall Street looked a little bit better on Tuesday morning, as many investors waited patiently to see what the Federal Reserve would discuss about its future monetary policy at its symposium la...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com It’s time for a breakdown of the biggest pre-market stock movers for Tuesday and the news that has them moving. Moving stocks this morning is an acquisition, a senior note of...
News, Short Squeeze, Breakout and More Instantly...
Aerie Pharmaceuticals Inc. Company Name:
AERI Stock Symbol:
NASDAQ Market:
Aerie Pharmaceuticals Inc. Website:
Leveraging Alcon’s robust commercial capabilities and resources to drive further growth and access to Rocklatan and Rhopressa Acquisition adds pharmaceutical research and development capabilities and further expertise for future product pipeline Expands Al...
Third Quarter Glaucoma Franchise Net Revenues of $36.1 Million, up 23% over Third Quarter 2021 Previously Announced Agreement to be Acquired by Alcon; Transaction Expected to Close in the Fourth Quarter of 2022 Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), a pharmaceut...
NEW YORK, NY / ACCESSWIRE / October 30, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Altra Industrial Motion Corp. (NA...